Results 131 to 140 of about 65,823 (297)

Evaluating the impact of COVID-19 on routine childhood immunizations coverage in Zambia.

open access: yesPLOS Global Public Health
There are growing concerns about the comeback of vaccine-preventable diseases. Epidemics exert shocks which affect other health performance indicators such as routine immunizations.
Kelvin Mwangilwa   +11 more
doaj   +1 more source

Infection risk in rheumatoid arthritis patients treated with biologic and targeted therapies

open access: yesRheumatology &Autoimmunity, EarlyView.
In this context, infections associated with each biologic and targeted drug are summarized to inform the stratification of RA patients, including the characteristics of the susceptible patients and their concomitant therapy. We aim to provide a benefit‐risk analysis for clinical decision, and vital indications for the prevention of highly correlated ...
Lujing Wang, Jieshi Lin, Jie Qian
wiley   +1 more source

J Infect Dis [PDF]

open access: yes
Background.Efforts are underway to strengthen Nigeria\u2019s routine immunization system, yet measuring impact poses a challenge. We document limitations in using administrative data from 12 states in Nigeria and explore alternative approaches.Methods.We

core  

Assessment of current colostrum feeding practices and passive transfer of immunity in dairy herds in Great Britain: A cross‐sectional study

open access: yesVeterinary Record, EarlyView.
Abstract Background Updated targets for measuring transfer of passive immunity (TPI) at the herd level have been suggested, but the current performance of dairy herds in Great Britain is unknown. Methods A cross‐sectional study was performed. Serum total protein (STP) data collected between October 2022 and October 2023 by 21 veterinary practices were ...
George Lindley   +3 more
wiley   +1 more source

The Economic Case for Expanding Vaccination Coverage of Children [PDF]

open access: yes
While childhood vaccination programs, such as WHO’s Expanded Program on Immunization, have had a dramatic impact on child morbidity and mortality worldwide, lack of coverage with several existing vaccines is responsible for large numbers of child deaths ...
Lois Privor-Dumm   +7 more
core  

Diagnostic antibodies at an inflection point: From discovery platforms to design‐oriented engineering

open access: yesVIEW, EarlyView.
This study systematically organizes the evolution of diagnostic antibodies from discovery platforms to design‐oriented engineering and analyzes the strengths and limitations of each approach. Meanwhile, it provides a critical, literature‐driven synthesis of current challenges, proposing integrated strategies for assay‐aware and function‐driven antibody
Qitao Song   +14 more
wiley   +1 more source

An evaluation of supplemental and routine immunization coverage in maiduguri metropolis, Borno state, Nigeria. [PDF]

open access: yes, 2008
Nigeria is currently the main focus of the polio eradication initiative. Strong routine immunization coverage offers better sustained protection to the most vulnerable age group (0-59 months) Maiduguri is the commercial nerve centre and the seat of ...
ZM, MANGORO, JP, AMBE, AP, BASSI
core  

Impact of a Structured Caesarean Reduction Strategy on Perinatal Outcomes: A Retrospective Ecological Time‐Trend Study

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To evaluate the long‐term impact of a structured, multidisciplinary CS reduction strategy in a high‐complexity Italian hospital. Design Retrospective ecological time‐trend study. Setting Tertiary obstetric care Italian centre. Sample 28 577 deliveries, ≥ 22 weeks' gestation, from 2014 to 2024 were analysed.
Stefania Fieni   +4 more
wiley   +1 more source

Prevention of Pneumococcal Disease Among Infants and Children: Use of 13-valent Pneumococcal Conjugate Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine : Recommendations of the Advisory Committee on Immunization Practices (ACIP) [PDF]

open access: yes
"On February 24, 2010, a 13-valent pneumococcal polysaccharide-protein conjugate vaccine (PCV13 [Prevnar 13, Wyeth Pharmaceuticals Inc., marketed by Pfizer Inc.]) was licensed by the Food and Drug Administration (FDA) for prevention of invasive ...

core  

Routine Immunization [PDF]

open access: yesInternational Journal of Infectious Diseases, 2010
openaire   +1 more source

Home - About - Disclaimer - Privacy